CAR-T Cell Therapy approved for Cancer
Central Idea The Drug Controller General of India (DCGI) has granted market authorization to CAR-T (Chimeric Antigen Receptor-T) cell therapy, a groundbreaking cancer treatment developed by ImmunoACT, an IIT-Bombay spin-off. This authorization paves the way for its commercial introduction in India. About CAR-T Cell Therapy What is it? CAR-T cell therapy stands for chimeric antigen… Continue reading CAR-T Cell Therapy approved for Cancer